Cyclobenzaprine Hydrochloride
NDC 0115-1437, Cyclobenzaprine Hydrochloride, capsule, extended release, from Amneal Pharmaceuticals of New York LLC.
- Product NDC
- 0115-1437
- Status
- Listed
- Labeler
- Amneal Pharmaceuticals of New York LLC
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA AUTHORIZED GENERIC
- Application
- NDA021777
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0115-1437 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CYCLOBENZAPRINE HYDROCHLORIDE30 mg/1
Pharmacologic classes
Centrally-mediated Muscle Relaxation [PE]; Muscle Relaxant [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0115-1437-13 | 00115143713 | 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0115-1437-13) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/dd546a0e-e5be-4232-8ad8-fcd7d5f9a903NADAC price for package 00115143713
GET /v1/drugs/nadac/00115143713
Use it
Look up 0115-1437 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0115-1437 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0115-1437. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.